News
Alnylam Pharmaceuticals has had a lot of excitement this year, with more good news potentially on the way. Summit ...
Glenmark Pharmaceuticals establishes Glenmark Consumer Care Limited to manufacture and market pharmaceutical and consumer ...
Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...
Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.
Explore more
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Sanofi spent $130 million outfitting the 260,000 square feet it now occupies for 2,000 employees at M Station West.
GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.
Sanofi to acquire clinical-stage biotechnology company, Vigil Neuroscience for $470 million: Paris Friday, May 23, 2025, 11:00 Hrs [IST] Sanofi, an innovative global healthcare co ...
Due to self-administration & preventive use of probiotics, besides doctors’ prescriptions, probiotic brands Enterogermina & ...
French pharma Sanofi has acquired the U.S.-based biotech firm Vigil Neuroscience for $470 million, aiming to bolster its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results